Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway
ConclusionsThis study showed that honokiol can enhance TMZ-induced apoptotic insults to glioma cells via an intrinsic mitochondrion-dependent mechanism. Our results suggest the therapeutic potential of honokiol to attenuate TMZ-induced side effects.Graphical abstract
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research
More News: Brain Tumor | Cancer & Oncology | Drugs & Pharmacology | Glioma | Mitochondria | Study | Temodar | Translocation